Artiva Biotherapeutics, Inc. Common Stock (ARTV)
Filed: 18 Jul 24, 5:55pm
Exhibit 107
Calculation of Filing Fee Tables
Form S-1
(Form Type)
Artiva Biotherapeutics, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
| Security Type | Security Class Title | Fee Rule | Amount Registered | Proposed Maximum Offering Price Per Share | Maximum Aggregate Offering Price(1) | Fee Rate | Amount of Registration Fee(2) | |||||||||
| Fees to Be Paid | Equity | Common Stock, $0.0001 par value per share | Rule 457(o) | — | — | $192,096,000 | 0.00014760 | $28,354 | ||||||||
| Total Offering Amounts | $192,096,000 | $28,354 | ||||||||||||||
| Total Fees Previously Paid | $23,628 | |||||||||||||||
| Total Fee Offsets | — | |||||||||||||||
| Net Fee Due | $4,726 | |||||||||||||||
| (1) | The registrant previously registered securities on the Registration Statement on Form S-1 (File No. 333-280568) having a proposed maximum aggregate offering price of $160,080,000, which was declared effective by the Securities and Exchange Commission on July 18, 2024. In accordance with Rule 462(b) under the Securities Act, an additional amount of securities having a proposed maximum aggregate offering price of $32,016,000 is hereby registered, which includes shares issuable upon the exercise of the underwriters’ option to purchase additional shares. |
| (2) | The registration fee is calculated in accordance with Rule 457(o) under the Securities Act of 1933, as amended, based on the proposed maximum aggregate offering price. |